Additionally, this medication improves blood sugar control, making it particularly beneficial for our patients with type 2 diabetes or prediabetes
Pattern matters far more than perfection
Listen and Adapt: Pay close attention to the body's signals, including energy levels and any medication side effects
One year post-discontinuation, 35.2% of patients (2,794) received an alternative obesity treatment: 27.4% received another medication, 13.7% received modifications and visits with a health care professional, and 0.6% received metabolic or bariatric surgery
Our doctors will recommend appropriate investigation, and where relevant referral, before an elective infusion
Wegovy is the first weight loss injection shown in clinical trials to reduce the risk of major cardiovascular events in people living with overweight or obesity who already have cardiovascular disease